A detailed history of Croban transactions in Pfizer Inc stock. As of the latest transaction made, Croban holds 24,245 shares of PFE stock, worth $597,639. This represents 0.41% of its overall portfolio holdings.

Number of Shares
24,245
Previous 25,685 5.61%
Holding current value
$597,639
Previous $622 Million 0.77%
% of portfolio
0.41%
Previous 0.53%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025

SELL
$23.29 - $25.88 $33,537 - $37,267
-1,440 Reduced 5.61%
24,245 $617 Million
Q2 2025

Aug 08, 2025

SELL
$21.59 - $24.84 $54,579 - $62,795
-2,528 Reduced 8.96%
25,685 $622 Million
Q1 2025

Apr 30, 2025

BUY
$25.01 - $27.13 $71,003 - $77,022
2,839 Added 11.19%
28,213 $715 Million
Q4 2024

Aug 19, 2025

SELL
$24.8 - $30.19 $7,712 - $9,389
-311 Reduced 1.21%
25,374 $673 Million
Q4 2023

Feb 07, 2025

BUY
$26.13 - $33.94 $663,022 - $861,193
25,374 New
25,374 $673 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $138B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Croban Portfolio

Follow Croban and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Croban, based on Form 13F filings with the SEC.

News

Stay updated on Croban with notifications on news.